Home » Featured » Page 36
Featured
Social media companies need to step up and use the technology they already have to limit extremist groups from spreading misinformation and conspiracy theories online, experts said Wednesday during a U.S. House Homeland Security Committee virtual forum on extremism during the COVID-19 pandemic.... Read More »
A group of Republican senators introduced legislation requires national security evaluation and clearance for all Chinese student visa holders taking part in activities related to COVID-19 vaccine research.
The COVID-19 Vaccine Protection Act – sponsored by Sens. Martha McSally (R-AZ), Rick... Read More »
Through its COVID-Local site, the Nuclear Threat Initiative (NTI) has released a guide of new metrics meant to guide local leaders and state officials in safely reopening the United States.
The site now includes interactive graphics and downloadable PDFs, meant to aid assessment of existing... Read More »
Several U.S. Senators have reached out to the leadership at the Federal Bureau of Investigation (FBI) and the Cybersecurity and Infrastructure Security Agency (CISA) about attempts by the Chinese to steal intellectual property related to COVID-19.
The FBI and CISA had sent out a joint notice,... Read More »
AstraZeneca has reached first agreements for at least 400 million doses of a potential COVID-19 vaccine developed by the University of Oxford, including 300 million for the United States.
First shipments will begin rolling out to the U.K. in September, then the United States in October. The... Read More »
A group of U.S. Senators recently called on the Trump administration officials to help secure personal protective equipment (PPE) and testing kits for firefighters and federal law enforcement personnel charged with fighting wildfires.
“Peak fire season comes closer every day. However, it is... Read More »
The Department of Health and Human Services (HHS) is awarding $11 billion in funding to support COVID-19 testing.
The Centers for Disease Control and Prevention (CDC) will provide $10.25 billion to states, territories, and local jurisdictions through its Epidemiology and Laboratory Capacity for... Read More »
In an effort to counter potential medical shortages, the United States federal government has awarded $354 million to the Phlow Corporation, with an eye on advanced manufacturing of essential medicines.
In all, that contract could stretch up to $812 million, thanks to a four-year base award of... Read More »
A bipartisan group of Senators introduced May 15 legislation designed to strengthen the nation’s bioeconomy.
The Bioeconomy Research and Development Act of 2020 seeks to advance research and development, advance biomanufacturing, develop the future bioeconomy workforce, and support various... Read More »
Another COVID-19 is being investigated for faults, resulting in the United States Food and Drug Administration (FDA) to warn people that the Abbott ID NOW point-of-care test may return inaccurate, false negative results.
The warning stems from some scientific studies that have identified... Read More »
U.S. Reps. Frank Pallone, Jr. (D-NJ) and Diana DeGette (D-CO) are asking officials at the Centers for Disease Control and Prevention (CDC) on the steps taken to further protect food production workers from the coronavirus.
There have been a series of COVID-19 outbreaks in food production... Read More »
Democrats in the U.S. House of Representatives introduced a $3 trillion aid package that would provide relief for Americans, fund COVID-19 testing, and bolster state and local health infrastructure and funding, among other initiatives.
The Health and Economic Recovery Omnibus Emergency Solutions... Read More »
Several Democrats in the U.S. House of Representatives are asking Attorney General William Barr for a briefing on legal action the Department of Justice has taken – or has threatened to take -- against state governments that have imposed strict public health and safety restrictions to combat... Read More »
Top U.S. health officials testified before the U.S. Senate Health, Education, Labor, and Pensions Committee on Tuesday, discussing the potential for future response to the COVID-19 pandemic, the need for and capabilities of testing, and the dangers of reopening workplaces and schools too... Read More »
Remdesivir has been shown to shorten the recovery time for patients suffering from COVID-19, and as a result, the National Institute of Allergy and Infectious Diseases (NIAID) has begun a clinical trial to see how it fairs when paired with the anti-inflammatory baricitinib.
“We now have solid... Read More »
The United States’ preparedness and response capabilities have buckled under the stress of the ongoing COVID-19 pandemic and proactive work is needed to meet the next infectious disease before it strikes, said experts during the Bipartisan Commission on Biodefense May 8 virtual... Read More »
Nearly $583 million has been dispatched to 1,385 Health Resources and Services Administration (HRSA)-funded health centers throughout the United States and its territories to bolster COVID-19 testing, the U.S. Department of Health and Human Services (HHS) announced last week.
“Widespread... Read More »
Researchers at Johns Hopkins Bloomberg School of Public Health expect to shortly begin two trials of convalescent plasma – plasma taken from recovered COVID-19 patients – next week, with an eye on reducing hospital strain and helping both high-risk populations and those getting sick at... Read More »
U.S. Rep. Brian Higgins (D-NY) will introduce a bill that would create a new agency within the Department of Health and Human Services, the National Medical Command (NMC).
This new independent agency would be charged with preparing for, monitoring, and responding to pandemics. Further, it would... Read More »
The first American participants in the Phase 1/2 clinical trial of the BNT162 vaccine program, created by Pfizer Inc. and BioNTech SE, have been dosed as the companies ramp up manufacturing capabilities to meet 2020/2021 capacity needs.
That vaccine is meant to treat COVID-19, the disease that... Read More »
Following the results of two clinical trials for the experimental antiviral drug remdesivir, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) last week, opening it to use as a treatment for those with severe cases of COVID-19.
“Based on evaluation of the... Read More »
A group of 14 Democratic U.S. senators is calling on Congress to include $8 billion in new funding for contact tracing to fight the COVID-19 virus.
Contact tracing is the process of tracking infected people to find out who they have been in contact with to stop the spread of the virus.... Read More »
Senate Democrats introduced legislation that lays out a framework for a coordinated federal response to the COVID-19 pandemic.
The Medical Supply Transparency and Delivery Act requires the president to utilize all available authorities under the Defense Production Act to mobilize a federal... Read More »
The Phase 3 SIMPLE trial of Gilead Sciences Inc’s antiviral drug remdesivir has reached its primary endpoint, supplying positive data that COVID-19 patients administered the drug early fared better than those treated later.
From 397 patients, the study revealed that 62 percent of patients... Read More »
Criticizing President Donald Trump’s unilateral decision to end funding for the World Health Organization (WHO) as reckless, Democratic members of the House Committee on Foreign Affairs called on the president to restore funding and to stop putting COVID-19 blame on the organization.
Chairman... Read More »
U.S. Rep. Frank Lucas (R-OK) introduced a bill in the House that authorizes additional scientific research to fight the novel coronavirus and other infectious diseases.
The legislation -- the Computing Opportunities to Vanquish Infectious Diseases Research Act of 2020 (the COVID Research Act)... Read More »
The Department of Health and Human Services (HHS) announced last week that the Centers for Disease Control and Prevention (CDC) is awarding $631 million to 64 jurisdictions in support of the COVID-19 response.
“This new funding secured from Congress by President Trump will help public health... Read More »
From flooding to wildfires to the novel coronavirus, health emergencies have dominated and redefined public life in the last year. Experts say that keeping Americans safe from these disasters requires a well-funded public health system focused on three key areas: prevention, preparedness, and... Read More »
Under legislation introduced by a collection of nine Democratic senators this week, AmeriCorps would take on more Americans and offer greater compensation, as part of a three-year response and recovery period linked to the COVID-19 pandemic.
The Pandemic Response and Opportunity Through National... Read More »
The spread of coronavirus in the United States has unveiled various levels of inequalities in society, including between major cities with more robust hospital systems and rural communities with less access to resources.
The COVID-19: A Frontline Guide for Local Decision-Makers, a global... Read More »
Despite high scores on the Global Health Security (GHS) index, the United States has fundamentally weak health security, the Nuclear Threat Initiative (NTI) warns, and its struggle with COVID-19 has emphasized its inadequate ability to deal with a pandemic.
COVID-19 has spawned more than... Read More »
U.S. Rep. Frank Pallone (D-NJ) is calling on the Trump Administration to develop a comprehensive COVID-19 testing strategy as part of its efforts to reopen the economy.
Pallone, chair of the House Energy and Commerce Committee, is concerned that the Trump Administration appears to be abandoning... Read More »
Legislation introduced in the U.S. House seeks to ensure greater accountability in the distribution of personal protective equipment (PPE) and other emergency resources under the Defense Protection Act and Stafford Act.
Specifically, the bill -- the Emergency Supply Chain Transparency Act --... Read More »
In a teleconference between experts from the Immunization Action Coalition, FasterCures and the U.S. Food and Drug Administration (FDA) on Friday, one thing was made abundantly clear: the world needs the best possible vaccines to combat COVID-19 as quickly as possible.
In the opinion of Dr.... Read More »
Congressional legislators on Friday introduced two bipartisan bills in the U.S. House of Representatives to bolster the Strategic National Stockpile (SNS), the nation’s repository of antibiotics, vaccines and other critical medical supplies that has been strained by the current coronavirus... Read More »
